Browse by UCL Departments and Centres
![[up]](/style/images/multi_up.png)
Up a levelGroup by: Author | Type
Number of items: 120.
A
Abeyakoon, O;
Latifoltojar, A;
Gong, F;
Papoutsaki, M-V;
Chowdhury, R;
Glaser, M;
Jeraj, H;
... Punwani, S; + view all
(2019)
Hyperpolarised 13C MRI: a new horizon for non-invasive diagnosis of aggressive breast cancer.
BJR case reports
, 5
(3)
, Article 20190026. 10.1259/bjrcr.20190026.
|
 |
|
Adeleke, S;
Latifoltojar, A;
Sidhu, H;
Galazi, M;
Shah, TT;
Clemente, J;
Davda, R;
... Punwani, S; + view all
(2019)
Localising occult prostate cancer metastasis with advanced imaging techniques (LOCATE trial): a prospective cohort, observational diagnostic accuracy trial investigating whole-body magnetic resonance imaging in radio-recurrent prostate cancer.
BMC Medical Imaging
, 19
, Article 90. 10.1186/s12880-019-0380-y.
|
|
|
Al-Mossawi, H;
Yager, N;
Taylor, CA;
Lau, E;
Danielli, S;
de Wit, J;
Gilchrist, J;
... Fairfax, BP; + view all
(2019)
Context-specific regulation of surface and soluble IL7R expression by an autoimmune risk allele.
Nature Communications
, 10
, Article 4575. 10.1038/s41467-019-12393-1.
|
|
|
Alifrangis, C;
McGovern, U;
Freeman, A;
Powles, T;
Linch, M;
(2019)
Molecular and histopathology directed therapy for advanced bladder cancer.
Nature Reviews Urology
, 16
(8)
pp. 465-483.
10.1038/s41585-019-0208-0.
|
|
|
Attard, G;
Conteduca, V;
Wetterskog, D;
(2019)
A multimodal approach to outcome prediction in metastatic castration-resistant prostate cancer by integrating functional imaging and plasma DNA analysis.
JCO Precision Oncology
10.1200/PO.18.00302.
(In press).
|
|
Attard, G;
Jayaram, A;
Wingate, A;
Wetterskog, K;
(2019)
Plasma Androgen Receptor Copy Number Status at Emergence of Metastatic Castration-Resistant Prostate Cancer: A Pooled Multicohort Analysis.
JCO Precision Oncology
, 3
10.1200/PO.19.00123.
|
|
Attard, G;
Wetterskog, D;
Jayaram, A;
Wingate, A;
(2019)
Plasma AR status and cabazitaxel in heavily-treated metastatic castration-resistant prostate cancer.
European Journal of Cancer
, 116
pp. 158-168.
10.1016/j.ejca.2019.05.007.
|
B
|
Barber, PR;
Weitsman, G;
Lawler, K;
Barrett, J;
Rowley, M;
Rodriguez-Justo, M;
Fisher, D;
... Ng, T; + view all
(2019)
HER2-HER3 heterodimer quantification by FRET-FLIM and patient subclass analysis of the COIN colorectal trial.
JNCI: Journal of the National Cancer Institute
10.1093/jnci/djz231.
(In press).
|
|
|
Beaton, L;
Tregidgo, HFJ;
Znati, SA;
Forsyth, S;
Clarkson, MJ;
Bandula, S;
Chouhan, M;
... Sharma, RA; + view all
(2019)
VEROnA Protocol: A Pilot, Open-Label, Single-Arm, Phase 0, Window-of-Opportunity Study of Vandetanib-Eluting Radiopaque Embolic Beads (BTG-002814) in Patients With Resectable Liver Malignancies.
JMIR Research Protocols
, 8
(10)
, Article e13696. 10.2196/13696.
|
|
|
Beedham, W;
Peck, G;
Richardson, S;
Tsang, K;
Fertleman, M;
Shipway, D;
(2019)
Head injury in the elderly – an overview for the physician.
Clinical Medicine
, 19
(2)
pp. 177-184.
10.7861/clinmedicine.19-2-177.
|
|
Bell, L;
Potts, H;
Williamson, E;
(2019)
P-17
Improving engagement in a health app: considerations in
designing a Micro-Randomised Trial.
Presented at: The 5th International Clinical Trials Methodology Conference (ICTMC 2019).
|
|
|
Bentham, RB;
Bryson, K;
Szabadkai, G;
(2019)
Biclustering Analysis of Co-regulation Patterns in Nuclear-Encoded Mitochondrial Genes and Metabolic Pathways.
Cancer Metabolism
, 1928
pp. 469-478.
10.1007/978-1-4939-9027-6_24.
|
|
Bi, WL;
Hosny, A;
Schabath, MB;
Giger, ML;
Birkbak, NJ;
Mehrtash, A;
Allison, T;
... Aerts, HJWL; + view all
(2019)
Artificial intelligence in cancer imaging: Clinical challenges and applications.
CA: A Cancer Journal for Clinicians
, 69
(2)
pp. 127-157.
10.3322/caac.21552.
|
|
|
Bilanges, B;
Posor, Y;
Vanhaesebroeck, B;
(2019)
PI3K isoforms in cell signalling and vesicle trafficking.
Nature Reviews Molecular Cell Biology
, 20
pp. 515-534.
10.1038/s41580-019-0129-z.
|
|
Biswas, D;
Birkbak, NJ;
Rosenthal, R;
Hiley, CT;
Lim, EL;
Papp, K;
Boeing, S;
... TRACERx Consortium; + view all
(2019)
A clonal expression biomarker associates with lung cancer mortality.
Nature Medicine
, 25
pp. 1540-1548.
10.1038/s41591-019-0595-z.
|
|
Black, JR;
Goldin, RD;
Foxton, M;
Marafioti, T;
Akarca, AU;
Pria, AD;
Brock, C;
... Pinato, DJ; + view all
(2019)
PD-L1 expressing granulomatous reaction as an on-target mechanism of steroid-refractory immune hepatotoxicity.
Immunotherapy
, 11
(7)
pp. 585-590.
10.2217/imt-2018-0187.
|
|
Budczies, J;
Allgäuer, M;
Litchfield, K;
Rempel, E;
Christopoulos, P;
Kazdal, D;
Endris, V;
... Stenzinger, A; + view all
(2019)
Optimizing panel-based tumor mutational burden (TMB) measurement.
Annals of Oncology
, 30
(9)
pp. 1496-1506.
10.1093/annonc/mdz205.
|
|
C
|
Cailleau, T;
Adams, LR;
Arora, N;
Kang, G-D;
Masterson, L;
Patel, N;
Hartley, JA;
... Howard, PW; + view all
(2019)
Potentiation of PBD Dimers by Lipophilicity Manipulation.
Current Topics in Medicinal Chemistry
, 19
(9)
pp. 741-752.
10.2174/1568026619666190401112517.
|
|
Carter, Thomas James;
(2019)
Magnetic Hyperthermia for the Treatment of Glioblastoma.
Doctoral thesis (Ph.D), UCL (University College London).
|
|
Chambers, P;
Jani, Y;
Wei, L;
Kipps, E;
Forster, MD;
Wong, ICK;
(2019)
Patient Factors and their Impact on Neutropenic Events: A Systematic review and meta-analysis.
Supportive Care in Cancer
, 27
(7)
pp. 2413-2424.
10.1007/s00520-019-04773-6.
|
|
Chan, TA;
Yarchoan, M;
Jaffee, E;
Swanton, C;
Quezada, SA;
Stenzinger, A;
Peters, S;
(2019)
Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic.
Annals of Oncology
, 30
(1)
pp. 44-56.
10.1093/annonc/mdy495.
|
|
|
Chemi, F;
Rothwell, DG;
McGranahan, N;
Gulati, S;
Abbosh, C;
Pearce, SP;
Zhou, C;
... TRACERx Consortium, .; + view all
(2019)
Pulmonary venous circulating tumor cell dissemination before tumor resection and disease relapse.
Nature Medicine
, 25
pp. 1534-1539.
10.1038/s41591-019-0593-1.
|
|
Chen, X;
Zhabyeyev, P;
Azad, AK;
Wang, W;
Minerath, RA;
DesAulniers, J;
Grueter, CE;
... Oudit, GY; + view all
(2019)
Endothelial and cardiomyocyte PI3Kβ divergently regulate cardiac remodelling in response to ischaemic injury.
Cardiovascular Research
, 115
(8)
pp. 1343-1356.
10.1093/cvr/cvy298.
|
|
Chung, HC;
Arkenau, H-T;
Lee, J;
Rha, SY;
Oh, D-Y;
Wyrwicz, L;
Kang, Y-K;
... Safran, H; + view all
(2019)
Avelumab (anti-PD-L1) as first-line switch-maintenance or second-line therapy in patients with advanced gastric or gastroesophageal junction cancer: phase 1b results from the JAVELIN Solid Tumor trial.
Journal for ImmunoTherapy of Cancer
, 7
, Article 30. 10.1186/s40425-019-0508-1.
|
|
|
Clarke, NW;
Ali, A;
Ingleby, FC;
Hoyle, A;
Amos, CL;
Attard, G;
Brawley, CD;
... James, ND; + view all
(2019)
Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial.
Annals of Oncology
10.1093/annonc/mdz396.
(In press).
|
|
Conteduca, V;
Jayaram, A;
Romero-Laorden, N;
Wetterskog, D;
Salvi, S;
Gurioli, G;
Scarpi, E;
... de Giorgi, U; + view all
(2019)
Plasma Androgen Receptor and Docetaxel for Metastatic Castration-resistant Prostate Cancer.
European Urology
10.1016/j.eururo.2018.09.049.
(In press).
|
|
|
Coombes, C;
Page, K;
Salari, R;
Hastings, RK;
Armstrong, AC;
Ahmed, S;
Ali, S;
... Shaw, JA; + view all
(2019)
Personalized detection of circulating tumor DNA antedates breast cancer metastatic recurrence.
Clinical Cancer Research
, 25
(14)
pp. 4255-4263.
10.1158/1078-0432.CCR-18-3663.
|
|
Crowley, C;
Butler, C;
Camilli, C;
Hynds, R;
Kolluri, KK;
Janes, SM;
De Coppi, P;
(2019)
Non-invasive longitudinal bioluminescence imaging of human mesoangioblasts in bioengineered esophagi.
Tissue Engineering Part C: Methods
, 25
(2)
pp. 103-113.
10.1089/ten.TEC.2018.0351.
|
|
D
|
de Bono, JS;
Concin, N;
Hong, DS;
Thistlethwaite, FC;
Machiels, J-P;
Arkenau, H-T;
Plummer, R;
... Lassen, U; + view all
(2019)
Tisotumab vedotin in patients with advanced or metastatic solid tumours (InnovaTV 201): a first-in-human, multicentre, phase 1-2 trial.
Lancet Oncology
, 20
(3)
pp. 383-393.
10.1016/S1470-2045(18)30859-3.
|
|
Dillon, MT;
Grove, L;
Newbold, KL;
Shaw, H;
Brown, NF;
Mendell, J;
Chen, S;
... Harrington, KJ; + view all
(2019)
Patritumab with Cetuximab plus Platinum-Containing Therapy in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: An Open-Label, Phase Ib Study.
Clinical Cancer Research
, 25
(2)
pp. 487-495.
10.1158/1078-0432.CCR-18-1539.
|
E
|
Evans, R;
Flores-Borja, F;
Nassiri, S;
Miranda, E;
Lawler, K;
Grigoriadis, A;
Monypenny, J;
... Ng, T; + view all
(2019)
Integrin-Mediated Macrophage Adhesion Promotes Lymphovascular Dissemination in Breast Cancer.
Cell Reports
, 27
(7)
1967-1978.e4.
10.1016/j.celrep.2019.04.076.
|
|
|
Evans, TRJ;
Dean, E;
Molife, LR;
Lopez, J;
Ranson, M;
El-Khouly, F;
Zubairi, I;
... Kristeleit, R; + view all
(2019)
Phase 1 dose-finding and pharmacokinetic study of eribulin-liposomal formulation in patients with solid tumours.
British Journal of Cancer
, 120
pp. 379-386.
10.1038/s41416-019-0377-x.
|
|
F
|
Forster, MD;
Dillon, MT;
Kocsis, J;
Remenár, É;
Pajkos, G;
Rolland, F;
Greenberg, J;
(2019)
Patritumab or placebo, with cetuximab plus platinum therapy in recurrent or metastatic squamous cell carcinoma of the head and neck: A randomised phase II study.
European Journal of Cancer
, 123
pp. 36-47.
10.1016/j.ejca.2019.08.017.
|
|
|
Foxall, E;
Staszowska, A;
Hirvonen, LM;
Georgouli, M;
Ciccioli, M;
Rimmer, A;
Williams, L;
... Wells, CM; + view all
(2019)
PAK4 Kinase Activity Plays a Crucial Role in the Podosome Ring of Myeloid Cells.
Cell Reports
, 29
(11)
3385-3393.e6.
10.1016/j.celrep.2019.11.016.
|
|
|
Frizziero, M;
Wang, X;
Chakrabarty, B;
Childs, A;
Luong, TV;
Walter, T;
Khan, MS;
... McNamara, MG; + view all
(2019)
Retrospective study on mixed neuroendocrine non-neuroendocrine neoplasms from five European centres.
World Journal of Gastroenterology
, 25
(39)
pp. 5991-6005.
10.3748/wjg.v25.i39.5991.
|
|
G
|
Golan, T;
Hammel, P;
Reni, M;
Van Cutsem, E;
Macarulla, T;
Hall, MJ;
Park, J-O;
... Kindler, HL; + view all
(2019)
Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer.
The New England Journal of Medicine
, 381
pp. 317-327.
10.1056/NEJMoa1903387.
|
|
González-Billalabeitia, E;
Conteduca, V;
Wetterskog, D;
Jayaram, A;
Attard, G;
(2019)
Circulating tumor DNA in advanced prostate cancer: transitioning from discovery to a clinically implemented test.
Prostate Cancer and Prostatic Diseases
, 22
pp. 195-205.
10.1038/s41391-018-0098-x.
|
|
Greenwood, HE;
McCormick, PN;
Gendron, T;
Glaser, M;
Pereira, R;
Maddocks, ODK;
Sander, K;
... Witney, TH; + view all
(2019)
Measurement of Tumor Antioxidant Capacity and Prediction of Chemotherapy Resistance in Preclinical Models of Ovarian Cancer by Positron Emission Tomography.
Clinical Cancer Research
, 25
(8)
pp. 2471-2482.
10.1158/1078-0432.CCR-18-3423.
|
H
|
Hamilton, N;
Hynds, R;
Gowers, K;
Tait, A;
Butler, C;
Hopper, C;
Burns, A;
... Janes, SM; + view all
(2019)
Using a 3D collagen matrix to deliver respiratory progenitor cells to decellularized trachea in vivo.
Tissue Engineering Part C: Methods
, 25
(2)
pp. 93-102.
10.1089/ten.TEC.2018.0241.
|
|
Hammel, P;
Kindler, HL;
Reni, M;
Van Cutsem, E;
Macarulla, T;
Hall, MJ;
Park, JO;
... Golan, T; + view all
(2019)
Health-related quality of life in patients with a germline BRCA mutation and metastatic pancreatic cancer receiving maintenance olaparib.
Annals of Oncology
10.1093/annonc/mdz406.
(In press).
|
|
|
Han, G;
Berhane, S;
Toyoda, H;
Bettinger, D;
Elshaarawy, O;
Chan, AWH;
Kirstein, M;
... Johnson, PJ; + view all
(2019)
Prediction of Survival Among Patients Receiving Transarterial Chemoembolization for Hepatocellular Carcinoma: A Response-Based Approach.
Hepatology
10.1002/hep.31022.
(In press).
|
|
|
Handle, F;
Prekovic, S;
Helsen, C;
Van den Broeck, T;
Smeets, E;
Moris, L;
Eerlings, R;
... Claessens, F; + view all
(2019)
Drivers of AR indifferent anti-androgen resistance in prostate cancer cells.
Scientific Reports
, 9
, Article 137. 10.1038/s41598-019-50220-1.
|
|
|
Hoyle, AP;
Ali, A;
James, ND;
Cook, A;
Parker, CC;
de Bono, JS;
Attard, G;
... STAMPEDE Investigators; + view all
(2019)
Abiraterone in "High-" and "Low-risk" Metastatic Hormone-sensitive Prostate Cancer.
European Urology
, 76
(6)
pp. 719-728.
10.1016/j.eururo.2019.08.006.
|
|
Hu, X;
Fujimoto, J;
Ying, L;
Fukuoka, J;
Ashizawa, K;
Sun, W;
Reuben, A;
... Zhang, J; + view all
(2019)
Multi-region exome sequencing reveals genomic evolution from preneoplasia to lung adenocarcinoma.
Nature Communications
, 10
, Article 2978. 10.1038/s41467-019-10877-8.
|
|
I
|
Ilson, DH;
Tabernero, J;
Prokharau, A;
Arkenau, H-T;
Ghidini, M;
Fujitani, K;
Van Cutsem, E;
... Shitara, K; + view all
(2019)
Efficacy and Safety of Trifluridine/Tipiracil Treatment in Patients With Metastatic Gastric Cancer Who Had Undergone Gastrectomy: Subgroup Analyses of a Randomized Clinical Trial.
JAMA Oncology
, 6
(1)
, Article e193531.. 10.1001/jamaoncol.2019.3531.
|
|
|
Ismail, Mazlina;
(2019)
Computational analysis of T cell receptor repertoires in health and disease.
Doctoral thesis (Ph.D), UCL (University College London).
|
J
|
Jones, GG;
Del Río, IB;
Sari, S;
Sekerim, A;
Young, LC;
Hartig, N;
Areso Zubiaur, I;
... Rodriguez-Viciana, P; + view all
(2019)
SHOC2 phosphatase-dependent RAF dimerization mediates resistance to MEK inhibition in RAS-mutant cancers.
Nature Communications
, 10
(1)
, Article 2532. 10.1038/s41467-019-10367-x.
|
|
|
Jones, RL;
Ratain, MJ;
O'Dwyer, PJ;
Siu, LL;
Jassem, J;
Medioni, J;
DeJonge, M;
... Schwartz, G; + view all
(2019)
Phase II randomised discontinuation trial of brivanib in patients with advanced solid tumours.
European Journal of Cancer
, 120
pp. 132-139.
10.1016/j.ejca.2019.07.024.
|
|
|
Jones, RP;
Psarelli, E-E;
Jackson, R;
Ghaneh, P;
Halloran, CM;
Palmer, DH;
Campbell, F;
... European Study Group for Pancreatic Cancer, .; + view all
(2019)
Patterns of Recurrence After Resection of Pancreatic Ductal Adenocarcinoma: A Secondary Analysis of the ESPAC-4 Randomized Adjuvant Chemotherapy Trial.
JAMA Surgery
10.1001/jamasurg.2019.3337.
(In press).
|
|
Joshi, K;
Robert de Massy, M;
Ismail, M;
Reading, JL;
Uddin, I;
Woolston, A;
Hatipoglu, E;
... Chain, B; + view all
(2019)
Spatial heterogeneity of the T cell receptor repertoire reflects the mutational landscape in lung cancer.
Nature Medicine
, 25
pp. 1549-1559.
10.1038/s41591-019-0592-2.
|
K
|
Kidd, AC;
Skrzypski, M;
Jamal-Hanjani, M;
Blyth, KG;
(2019)
Cancer cachexia in thoracic malignancy: a narrative review.
Current Opinion in Supportive and Palliative Care
, 13
(4)
pp. 316-322.
10.1097/SPC.0000000000000465.
|
|
Kim, RD;
Sarker, D;
Meyer, T;
Yau, T;
Macarulla, T;
Park, J-W;
Choo, SP;
... Kang, Y-K; + view all
(2019)
First-in-Human Phase I Study of Fisogatinib (BLU-554) Validates Aberrant Fibroblast Growth Factor 19 Signaling as a Driver Event in Hepatocellular Carcinoma.
Cancer Discovery
, 9
(12)
pp. 1696-1707.
10.1158/2159-8290.CD-19-0555.
|
|
Kleftogiannis, D;
Punta, M;
Jayaram, A;
Sandhu, S;
Wong, SQ;
Gasi Tandefelt, D;
Conteduca, V;
... Lise, S; + view all
(2019)
Identification of single nucleotide variants using position-specific error estimation in deep sequencing data.
BMC Med Genomics
, 12
(1)
, Article 115. 10.1186/s12920-019-0557-9.
|
|
|
Kopetz, S;
Grothey, A;
Yaeger, R;
Van Cutsem, E;
Desai, J;
Yoshino, T;
Wasan, H;
... Tabernero, J; + view all
(2019)
Encorafenib, Binimetinib, and Cetuximab in BRAF V600E-Mutated Colorectal Cancer.
The New England Journal of Medicine
, 381
(17)
pp. 1632-1643.
10.1056/NEJMoa1908075.
|
|
Kristeleit, RS;
Oaknin, A;
Ray-Coquard, I;
Leary, A;
Balmaña, J;
Drew, Y;
Oza, AM;
... McNeish, IA; + view all
(2019)
Antitumor activity of the poly(ADP-ribose) polymerase inhibitor rucaparib as monotherapy in patients with platinum-sensitive, relapsed, BRCA-mutated, high-grade ovarian cancer, and an update on safety.
International Journal of Gynecological Cancer
, 29
(9)
pp. 1396-1404.
10.1136/ijgc-2019-000623.
|
|
L
|
Lechner, M;
Breeze, CE;
O'Mahony, JF;
Masterson, L;
(2019)
Early detection of HPV-associated oropharyngeal cancer.
[Letter].
Lancet
, 393
(10186)
p. 2123.
10.1016/S0140-6736(19)30227-2.
|
|
Lechner, M;
Jones, OS;
Breeze, CE;
Gilson, R;
(2019)
Gender-neutral HPV vaccination in the UK, rising male oropharyngeal cancer rates, and lack of HPV awareness.
[Letter].
Lancet Infectious Diseases
, 19
(2)
pp. 131-132.
10.1016/S1473-3099(18)30802-8.
|
|
Lee, DDH;
Petris, A;
Hynds, RE;
O'Callaghan, C;
(2019)
Ciliated Epithelial Cell Differentiation at Air-Liquid Interface Using Commercially Available Culture Media.
Methods in Molecular Biology
, 2109
pp. 275-291.
10.1007/7651_2019_269.
|
|
Lee, SM;
Upadhyay, S;
Lewanski, C;
Falk, S;
Skailes, G;
Woll, PJ;
Hatton, M;
... Hackshaw, A; + view all
(2019)
The clinical role of VeriStrat testing in patients with advanced non-small cell lung cancer considered unfit for first-line platinum-based chemotherapy.
European Journal of Cancer
, 120
pp. 86-96.
10.1016/j.ejca.2019.07.025.
|
|
|
Lin, CC;
Arkenau, HT;
Lu, S;
Sachdev, J;
de Castro Carpeño, J;
Mita, M;
Dziadziuszko, R;
... Weiss, GJ; + view all
(2019)
A phase 1, open-label, dose-escalation trial of oral TSR-011 in patients with advanced solid tumours and lymphomas.
British Journal of Cancer
, 121
pp. 131-138.
10.1038/s41416-019-0503-9.
|
|
|
Livanos, Maria;
(2019)
Production of DARPins in the Yeast Pichia pastoris.
Doctoral thesis (Ph.D), UCL (University College London).
|
|
Loveday, C;
Sud, A;
Litchfield, K;
Levy, M;
Holroyd, A;
Broderick, P;
Kote-Jarai, Z;
... Turnbull, C; + view all
(2019)
Runs of homozygosity and testicular cancer risk.
Andrology
, 7
(4)
pp. 555-564.
10.1111/andr.12667.
|
|
Luxton, HJ;
Simpson, BS;
Mills, IG;
Brindle, NR;
Ahmed, Z;
Stavrinides, V;
Heavey, S;
... Whitaker, HC; + view all
(2019)
The Oncogene Metadherin Interacts with the Known Splicing Proteins YTHDC1, Sam68 and T-STAR and Plays a Novel Role in Alternative mRNA Splicing.
Cancers
, 11
(9)
, Article 1233. 10.3390/cancers11091233.
|
|
M
|
Madsen, RR;
Knox, RG;
Pearce, W;
Lopez, S;
Mahler-Araujo, B;
McGranahan, N;
Vanhaesebroeck, B;
(2019)
Oncogenic PIK3CA promotes cellular stemness in an allele dose-dependent manner.
Proceedings of the National Academy of Sciences of The United States of America
10.1073/pnas.1821093116.
(In press).
|
|
|
Maggio, V;
Canovas, V;
Felix, AJ;
Gomez, V;
de Torres, I;
Eugenia Semidey, M;
Morote, J;
... Paciucci, R; + view all
(2019)
A novel DNA-binding motif in prostate tumor overexpressed-1 (PTOV1) required for the expression of ALDH1A1 and CCNG2 in cancer cells.
Cancer Letters
, 452
pp. 158-167.
10.1016/j.canlet.2019.03.019.
|
|
|
Mahmud-Al-Rafat, A;
Majumder, A;
Rahman, KMT;
Hasan, AMM;
Islam, KMD;
Taylor-Robinson, AW;
Billah, MM;
(2019)
Decoding the enigma of antiviral crisis: Does one target molecule regulate all?
Cytokine
, 115
pp. 13-23.
10.1016/j.cyto.2018.12.008.
|
|
|
Mak, G;
Soria, J-C;
Blagden, SP;
Plummer, R;
Fleming, RA;
Nebot, N;
Zhang, J;
... Arkenau, H-T; + view all
(2019)
A phase Ib dose-finding, pharmacokinetic study of the focal adhesion kinase inhibitor GSK2256098 and trametinib in patients with advanced solid tumours.
British Journal of Cancer
(120)
pp. 975-981.
10.1038/s41416-019-0452-3.
|
|
|
Martinez, V;
Pankova, V;
Krasney, L;
Singh, T;
White, I;
Benjamin, A;
dertsching, S;
... Acton, S; + view all
(2019)
Conduit integrity is compromised during acute lymph node expansion.
BioRxiv: Cold Spring Harbor, NY, USA.
|
|
Martinez, VG;
Pankova, V;
Krasny, L;
Singh, T;
Makris, S;
White, IJ;
Benjamin, AC;
... Acton, SE; + view all
(2019)
Fibroblastic Reticular Cells Control Conduit Matrix Deposition during Lymph Node Expansion.
Cell Reports
, 29
(9)
2810-2822.e5.
10.1016/j.celrep.2019.10.103.
|
|
|
Martínez-Mármol, R;
Mohannak, N;
Qian, L;
Wang, T;
Gormal, RS;
Ruitenberg, MJ;
Vanhaesebroeck, B;
... Meunier, FA; + view all
(2019)
p110δ PI 3-kinase inhibition perturbs APP and TNFα trafficking, reduces plaque burden, dampens neuroinflammation and prevents cognitive decline in an Alzheimer's disease mouse model.
The Journal of Neuroscience
, 39
(40)
pp. 7976-7991.
10.1523/JNEUROSCI.0674-19.2019.
|
|
McGranahan, N;
Swanton, C;
(2019)
Neoantigen quality, not quantity.
Science Translational Medicine
, 11
(506)
, Article eaax7918. 10.1126/scitranslmed.aax7918.
|
|
|
McLean, BA;
Patel, VB;
Zhabyeyev, P;
Chen, X;
Basu, R;
Wang, F;
Shah, S;
... Oudit, GY; + view all
(2019)
PI3Kα Pathway Inhibition With Doxorubicin Treatment Results in Distinct Biventricular Atrophy and Remodeling With Right Ventricular Dysfunction.
Journal of the American Heart Association
, 8
(9)
, Article e010961. 10.1161/JAHA.118.010961.
|
|
|
Meric-Bernstam, F;
Hurwitz, H;
Raghav, KPS;
McWilliams, RR;
Fakih, M;
VanderWalde, A;
Swanton, C;
... Hainsworth, J; + view all
(2019)
Pertuzumab plus trastuzumab for HER2-amplified metastatic colorectal cancer (MyPathway): an updated report from a multicentre, open-label, phase 2a, multiple basket study.
Lancet Oncology
, 20
(4)
pp. 518-530.
10.1016/S1470-2045(18)30904-5.
|
|
Messaoudene, M;
Mourikis, TP;
Michels, J;
Fu, Y;
Bonvalet, M;
Lacroix-Trikki, M;
Routy, B;
... Zitvogel, L; + view all
(2019)
T-cell bispecific antibodies in node-positive breast cancer: novel therapeutic avenue for MHC class I loss variants.
Annals of Oncology
, 30
(6)
pp. 934-944.
10.1093/annonc/mdz112.
|
|
Miles, A;
Taylor, SA;
Evans, REC;
Halligan, S;
Beare, S;
Bridgewater, J;
Goh, V;
... Yu, D; + view all
(2019)
Patient preferences for whole-body MRI or conventional staging pathways in lung and colorectal cancer: a discrete choice experiment.
European Radiology
, 29
(7)
pp. 3889-3900.
10.1007/s00330-019-06153-4.
|
|
|
Moore, DA;
Kushnir, M;
Mak, G;
Winter, H;
Curiel, T;
Voskoboynik, M;
Moschetta, M;
... Arkenau, HT; + view all
(2019)
Prospective analysis of 895 patients on a UK Genomics Review Board.
ESMO Open
, 4
(2)
, Article e000469. 10.1136/esmoopen-2018-000469.
|
|
|
Moore, DA;
Sereno, M;
Das, M;
Baena Acevedo, JD;
Sinnadurai, S;
Smith, C;
McSweeney, A;
... Le Quesne, J; + view all
(2019)
In situ growth in early lung adenocarcinoma may represent precursor growth or invasive clone outgrowth-a clinically relevant distinction.
Modern Pathology
10.1038/s41379-019-0257-1.
(In press).
|
|
Mourikis, TP;
Benedetti, L;
Foxall, E;
Temelkovski, D;
Nulsen, J;
Perner, J;
Cereda, M;
... Ciccarelli, FD; + view all
(2019)
Patient-specific cancer genes contribute to recurrently perturbed pathways and establish therapeutic vulnerabilities in esophageal adenocarcinoma.
Nature Communications
, 10
(1)
, Article 3101. 10.1038/s41467-019-10898-3.
|
|
N
|
Naumann, RW;
Hollebecque, A;
Meyer, T;
Devlin, M-J;
Oaknin, A;
Kerger, J;
López-Picazo, JM;
... Moore, KN; + view all
(2019)
Safety and Efficacy of Nivolumab Monotherapy in Recurrent or Metastatic Cervical, Vaginal, or Vulvar Carcinoma: Results From the Phase I/II CheckMate 358 Trial.
Journal of Clinical Oncology
, 37
(31)
pp. 2825-2834.
10.1200/JCO.19.00739.
|
O
|
Ogunlade, O;
Ho, J;
Kalber, T;
Hynds, R;
Zhang, E;
Janes, SM;
Birchall, M;
... Beard, P; + view all
(2019)
Monitoring neovascularization and integration of decellularized human scaffolds using photoacoustic imaging.
Photoacoustics
, 13
pp. 76-84.
10.1016/j.pacs.2019.01.001.
(In press).
|
|
P
|
Parry, MA;
Srivastava, S;
Ali, A;
Cannistraci, A;
Antonello, J;
Barros-Silva, JD;
Ubertini, V;
... Baena, E; + view all
(2019)
Genomic Evaluation of Multiparametric Magnetic Resonance Imaging-visible and -nonvisible Lesions in Clinically Localised Prostate Cancer.
European Urology Oncology
, 2
(1)
pp. 1-11.
10.1016/j.euo.2018.08.005.
|
|
|
Paz, K;
Flynn, R;
Du, J;
Tannheimer, S;
Johnson, AJ;
Dong, S;
Stark, A-K;
... Blazar, BR; + view all
(2019)
Targeting PI3Kδ function for amelioration of murine chronic graft‐versus‐host disease.
American Journal of Transplantation
, 19
(6)
pp. 1820-1830.
10.1111/ajt.15305.
|
|
Pinato, DJ;
Mauri, FA;
Spina, P;
Cain, O;
Siddique, A;
Goldin, R;
Victor, S;
... Sharma, R; + view all
(2019)
Clinical implications of heterogeneity in PD-L1 immunohistochemical detection in hepatocellular carcinoma: the Blueprint-HCC study.
British Journal of Cancer
, 120
(12)
pp. 1033-1036.
10.1038/s41416-019-0466-x.
|
|
|
Plesner, T;
Arkenau, HT;
Gay, F;
Minnema, MC;
Boccadoro, M;
Moreau, P;
Cavenagh, J;
... Richardson, PG; + view all
(2019)
Enduring efficacy and tolerability of daratumumab in combination with lenalidomide and dexamethasone in patients with relapsed or relapsed/refractory multiple myeloma (GEN503): final results of an open-label, phase 1/2 study.
British Journal of Haematology
, 186
(3)
e35-e39.
10.1111/bjh.15879.
|
|
Powles, T;
Kockx, M;
Rodriguez-Vida, A;
Duran, I;
Crabb, SJ;
Van Der Heijden, MS;
Szabados, B;
... Castellano, D; + view all
(2019)
Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial.
Nature Medicine
, 25
(11)
pp. 1706-1714.
10.1038/s41591-019-0628-7.
|
|
Q
|
Qayyum, MS;
Hayat, H;
Matharu, RK;
Tabish, TA;
Edirisinghe, M;
(2019)
Boron nitride nanoscrolls: Structure, synthesis, and applications.
Applied Physics Reviews
, 6
(2)
, Article 021310. 10.1063/1.5092547.
|
|
Qin, Xiao;
Sufi, Jahangir;
Vlckova, Petra;
Kyriakidou, Pelagia;
Acton, Sophie;
Li, Vivian;
Nitz, Mark;
(2019)
Single-Cell Signalling Analysis of Heterocellular Organoids.
BioRxiv: Cold Spring Harbor, NY, USA.
|
|
|
Qin, S;
Finn, RS;
Kudo, M;
Meyer, T;
Vogel, A;
Ducreux, M;
Macarulla, TM;
... Zhu, AX; + view all
(2019)
RATIONALE 301 study: tislelizumab versus sorafenib as first-line treatment for unresectable hepatocellular carcinoma.
Future Oncology
, 15
(16)
pp. 1811-1822.
10.2217/fon-2019-0097.
|
|
R
|
Rahman, B;
Lanceley, A;
Kristeleit, R;
Ledermann, J;
Lockley, M;
McCormack, M;
Mould, T;
(2019)
Mainstreamed genetic testing for women with ovarian cancer: first-year experience.
Journal of Medical Genetics
, 56
(3)
pp. 195-198.
10.1136/jmedgenet-2017-105140.
|
|
Ramage, JK;
Punia, P;
Faluyi, O;
Frilling, A;
Meyer, T;
Saharan, R;
Valle, JW;
(2019)
Observational Study to Assess Quality of Life in Patients with Pancreatic Neuroendocrine Tumors Receiving Treatment with Everolimus: The OBLIQUE Study (UK Phase IV Trial).
Neuroendocrinology
, 108
(4)
pp. 317-327.
10.1159/000497330.
|
|
Raza, SEA;
AbdulJabbar, K;
Jamal-Hanjani, M;
Veeriah, S;
Le Quesne, J;
Swanton, C;
Yuan, Y;
(2019)
Deconvolving Convolutional Neural Network for Cell Detection.
In:
2019 IEEE 16th International Symposium on Biomedical Imaging (ISBI 2019).
(pp. pp. 891-894).
IEEE: Venice, Italy,.
|
|
|
Richardson, S;
Brian, D;
Grandage, V;
Hough, R;
Kottaridis, P;
Mansour, M;
Payne, EMC;
(2019)
Intensive Chemotherapy Is Associated With Poor Overall Survival in Autoimmune Disease-associated Myeloid Malignancies.
HemaSphere
, 3
(1)
, Article e164. 10.1097/HS9.0000000000000164.
|
|
|
Rizzo, FM;
Vesely, C;
Childs, A;
Marafioti, T;
Khan, MS;
Mandair, D;
Cives, M;
... Meyer, T; + view all
(2019)
Circulating tumour cells and their association with bone metastases in patients with neuroendocrine tumours.
British Journal of Cancer
, 120
(3)
pp. 294-300.
10.1038/s41416-018-0367-4.
|
|
Rooshenas, L;
Scott, LJ;
Blazeby, JM;
Rogers, CA;
Tilling, KM;
Husbands, S;
Conefrey, C;
... Wheatley, T; + view all
(2019)
The QuinteT Recruitment Intervention supported five randomized trials to recruit to target: a mixed-methods evaluation.
Journal of Clinical Epidemiology
, 106
pp. 108-120.
10.1016/j.jclinepi.2018.10.004.
|
|
Rosenthal, R;
Cadieux, EL;
Salgado, R;
Bakir, MA;
Moore, DA;
Hiley, CT;
Lund, T;
... TRACERx consortium; + view all
(2019)
Neoantigen-directed immune escape in lung cancer evolution.
Nature
10.1038/s41586-019-1032-7.
(In press).
|
S
|
Schiavone, F;
Bathia, R;
Letchmanan, K;
Masters, L;
Amos, C;
Bara, A;
Brown, L;
... Sydes, MR; + view all
(2019)
This is a platform alteration: a trial management perspective on the operational aspects of adaptive and platform and umbrella protocols.
Trials
, 20
, Article 264. 10.1186/s13063-019-3216-8.
|
|
Shah, MA;
Kojima, T;
Hochhauser, D;
Enzinger, P;
Raimbourg, J;
Hollebecque, A;
Lordick, F;
... Kato, K; + view all
(2019)
Efficacy and Safety of Pembrolizumab for Heavily Pretreated Patients With Advanced, Metastatic Adenocarcinoma or Squamous Cell Carcinoma of the Esophagus. The Phase 2 KEYNOTE-180 Study.
JAMA Oncology
, 5
(4)
pp. 546-550.
10.1001/jamaoncol.2018.5441.
|
|
Sharif, H;
Singh, I;
Kouser, L;
Mösges, R;
Bonny, M-A;
Karamani, A;
Parkin, RV;
... Shamji, MH; + view all
(2019)
Immunologic Mechanisms of Short-course of Lolium Perenne Peptide Immunotherapy: A Randomized Double-Blind Placebo-Controlled Trial.
Journal of Allergy and Clinical Immunology
, 144
(3)
pp. 738-749.
10.1016/j.jaci.2019.02.023.
|
|
Shevtsov, M;
Stangl, S;
Nikolaev, B;
Yakovleva, L;
Marchenko, Y;
Tagaeva, R;
Sievert, W;
... Multhoff, G; + view all
(2019)
Granzyme B Functionalized Nanoparticles Targeting Membrane Hsp70‐Positive Tumors for Multimodal Cancer Theranostics.
Small
, 15
(13)
, Article 1900205. 10.1002/smll.201900205.
|
|
Singh, AN;
Oehler, J;
Torrecilla, I;
Kilgas, S;
Li, S;
Vaz, B;
Guérillon, C;
... Ramadan, K; + view all
(2019)
The p97-Ataxin 3 complex regulates homeostasis of the DNA damage response E3 ubiquitin ligase RNF8.
The EMBO Journal
, 38
(21)
, Article e102361. 10.15252/embj.2019102361.
|
|
|
Smeland, S;
Ingleby, F;
Many other authors, TPUTP;
Whelan, J;
Sydes, MR;
(2019)
Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 cohort.
European Journal of Cancer
, 109
pp. 36-50.
10.1016/j.ejca.2018.11.027.
|
|
|
Steele, CD;
Tarabichi, M;
Oukrif, D;
Webster, AP;
Ye, H;
Fittall, M;
Lombard, P;
... Pillay, N; + view all
(2019)
Undifferentiated Sarcomas Develop through Distinct Evolutionary Pathways.
Cancer Cell
, 35
(3)
441-456.e8.
10.1016/j.ccell.2019.02.002.
|
|
|
Stefano, P;
Ivana, M;
Arianna, G;
Letizia, Z;
Angelo, G;
Rosella, C;
Roberta, B;
... Andrea, G; + view all
(2019)
Identification of microRNAs and relative target genes in Moringa oleifera leaf and callus.
Scientific Reports
, 9
, Article 15145. 10.1038/s41598-019-51100-4.
|
|
|
Stein, A;
Dalton, L;
Rapa, E;
Bluebond-Langner, M;
Hanington, L;
Stein, KF;
Ziebland, S;
... Yousafzai, A; + view all
(2019)
Communication with children and adolescents about the diagnosis of their own life-threatening condition.
The Lancet
, 393
(10176)
pp. 1150-1163.
10.1016/S0140-6736(18)33201-X.
|
|
Strasser, S;
Abou-Alfa, G;
Mollon, P;
Meyer, T;
Cheng, A;
El-Khoueiry, A;
Kelley, R;
... Freemantle, N; + view all
(2019)
Quality-adjusted life-years accrued with cabozantinib in patients with advanced hepatocellular carcinoma in the CELESTIAL trial.
Presented at: Gastroenterological Society of Australia (GESA) Australian Gastroenterology Week (AGW) “The Universe Within”, Adelaide, Australia.
|
T
|
Taylor, SA;
Mallett, S;
Beare, S;
Bhatnagar, G;
Blunt, D;
Boavida, P;
Bridgewater, J;
... Streamline investigators; + view all
(2019)
Diagnostic accuracy of whole-body MRI versus standard imaging pathways for metastatic disease in newly diagnosed colorectal cancer: the prospective Streamline C trial.
The Lancet Gastroenterology & Hepatology
, 4
(7)
pp. 529-537.
10.1016/S2468-1253(19)30056-1.
|
|
|
Teixeira, VH;
Pipinikas, CP;
Pennycuick, A;
Lee-Six, H;
Chandrasekharan, D;
Beane, J;
Morris, TJ;
... Janes, SM; + view all
(2019)
Deciphering the genomic, epigenomic, and transcriptomic landscapes of pre-invasive lung cancer lesions.
Nature Medicine
, 25
pp. 517-525.
10.1038/s41591-018-0323-0.
|
|
Tombal, B;
Saad, F;
Penson, D;
Hussain, M;
Sternberg, CN;
Morlock, R;
Ramaswamy, K;
... Attard, G; + view all
(2019)
Patient-reported outcomes following enzalutamide or placebo in men with non-metastatic, castration-resistant prostate cancer (PROSPER): a multicentre, randomised, double-blind, phase 3 trial.
Lancet Oncology
, 20
(4)
pp. 556-569.
10.1016/S1470-2045(18)30898-2.
|
|
Trebeschi, S;
Drago, SG;
Birkbak, NJ;
Kurilova, I;
Calin, AM;
Pizzi, AD;
Lalezari, F;
... Aerts, HJWL; + view all
(2019)
Predicting response to cancer immunotherapy using noninvasive radiomic biomarkers.
Annals of Oncology
, 30
(6)
pp. 998-1004.
10.1093/annonc/mdz108.
|
|
U
|
Uddin, I;
Joshi, K;
Oakes, T;
Heather, JM;
Swanton, C;
TRACERx consortium, .;
Chain, B;
(2019)
An Economical, Quantitative, and Robust Protocol for High-Throughput T Cell Receptor Sequencing from Tumor or Blood.
Cancer Immunosurveillance: Methods and Protocols
pp. 15-42.
10.1007/978-1-4939-8885-3_2.
|
|
Uddin, I;
Woolston, A;
Peacock, T;
Joshi, K;
Ismail, M;
Ronel, T;
Husovsky, C;
(2019)
Quantitative analysis of the T cell receptor repertoire.
Methods in Enzymology
, 629
pp. 465-492.
10.1016/bs.mie.2019.05.054.
|
V
|
Vaarwerk, Bas;
Schoot, Reineke A;
Maurice-Stam, Heleen;
Slater, Olga;
Hartley, Benjamin;
Saeed, Peerooz;
Gajdosova, Eva;
... Merks, Johannes HM; + view all
(2019)
Psychosocial well-being of long-term survivors of pediatric head-neck rhabdomyosarcoma.
Pediatric Blood & Cancer
, 66
(2)
, Article e27498. 10.1002/pbc.27498.
|
|
|
van Noesel, MM;
Orbach, D;
Brennan, B;
Kelsey, A;
Zanetti, I;
de Salvo, GL;
Gaze, MN;
... Ferrari, A; + view all
(2019)
Outcome and prognostic factors in pediatric malignant peripheral nerve sheath tumors: An analysis of the European Pediatric Soft Tissue Sarcoma Group (EpSSG) NRSTS-2005 prospective study.
Pediatric Blood and Cancer
, 66
(10)
, Article e27833. 10.1002/pbc.27833.
|
|
|
Vanhaesebroeck, B;
Bilanges, B;
Madsen, RR;
Dale, KL;
Lau, E;
Vladimirou, E;
(2019)
Perspective: Potential Impact and Therapeutic Implications of Oncogenic PI3K Activation on Chromosomal Instability.
Biomolecules
, 9
(8)
, Article 331. 10.3390/biom9080331.
|
|
W
|
Winter, H;
Kaisaki, PJ;
Harvey, J;
Giacopuzzi, E;
Ferla, MP;
Pentony, MM;
Knight, SJL;
... McCullagh, JSO; + view all
(2019)
Identification of Circulating Genomic and Metabolic Biomarkers in Intrahepatic Cholangiocarcinoma.
Cancers
, 11
(12)
, Article 1895. 10.3390/cancers11121895.
|
|
|
Wolf, Y;
Bartok, O;
Patkar, S;
Bar Eli, G;
Cohen, S;
Litchfield, K;
Levy, R;
... Samuels, Y; + view all
(2019)
UVB-Induced Tumor Heterogeneity Diminishes Immune Response in Melanoma.
Cell
, 179
(1)
219-235.e21.
10.1016/j.cell.2019.08.032.
|
|
|
Woodcock, HV;
Eley, JD;
Guillotin, D;
Plate, M;
Nanthakumar, CB;
Martufi, M;
Peace, S;
... Chambers, RC; + view all
(2019)
The mTORC1/4E-BP1 axis represents a critical signaling node during fibrogenesis.
Nature Communications
, 10
, Article 6. 10.1038/s41467-018-07858-8.
|
|
|
Wu, A;
Attard, G;
(2019)
Plasma DNA Analysis in Prostate Cancer: Opportunities for Improving Clinical Management.
Clinical Chemistry
, 65
(1)
10.1373/clinchem.2018.287250.
|
Z
|
Zhabyeyev, P;
Chen, X;
Vanhaesebroeck, B;
Oudit, GY;
(2019)
PI3Kα in cardioprotection: Cytoskeleton, late Na+ current, and mechanism of arrhythmias.
Channels
, 13
(1)
pp. 520-532.
10.1080/19336950.2019.1697127.
|
|
|
Zhabyeyev, P;
McLean, B;
Chen, X;
Vanhaesebroeck, B;
Oudit, GY;
(2019)
Inhibition of PI3Kinase-α is pro-arrhythmic and associated with enhanced late Na⁺ current, contractility, and Ca²⁺ release in murine hearts.
Journal of Molecular and Cellular Cardiology
, 132
pp. 98-109.
10.1016/j.yjmcc.2019.05.008.
|
